| Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure K Usui, TD Bradley, J Spaak, CM Ryan, T Kubo, Y Kaneko, JS Floras Journal of the American College of Cardiology 45 (12), 2008-2011, 2005 | 287 | 2005 |
| Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial JB Cohen, TC Hanff, P William, N Sweitzer, NR Rosado-Santander, ... The Lancet Respiratory Medicine 9 (3), 275-284, 2021 | 237 | 2021 |
| Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea J Spaak, ZJ Egri, T Kubo, E Yu, SI Ando, Y Kaneko, K Usui, TD Bradley, ... Hypertension 46 (6), 1327-1332, 2005 | 227 | 2005 |
| Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction: the SWEDEHEART registry (Swedish Web-System for Enhancement and … L Desta, T Jernberg, I Löfman, C Hofman-Bang, I Hagerman, J Spaak, ... JACC: Heart Failure 3 (3), 234-242, 2015 | 200 | 2015 |
| Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology … GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and haemostasis 120 (12), 1597-1628, 2020 | 189 | 2020 |
| Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation JJ Carrero, M Evans, K Szummer, J Spaak, L Lindhagen, R Edfors, ... Jama 311 (9), 919-928, 2014 | 182 | 2014 |
| Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter J Spaak, AC Merlocco, GJ Soleas, G Tomlinson, BL Morris, P Picton, ... American Journal of Physiology-Heart and Circulatory Physiology 294 (2 …, 2008 | 143 | 2008 |
| Dose-related effects of red wine and alcohol on heart rate variability J Spaak, G Tomlinson, CL McGowan, GJ Soleas, BL Morris, P Picton, ... American Journal of Physiology-Heart and Circulatory Physiology 298 (6 …, 2010 | 101 | 2010 |
| Inverse relationship of subjective daytime sleepiness to sympathetic activity in patients with heart failure and obstructive sleep apnea LT Montemurro, JS Floras, PJ Millar, T Kasai, JM Gabriel, J Spaak, ... Chest 142 (5), 1222-1228, 2012 | 90 | 2012 |
| Long-term bed rest-induced reductions in stroke volume during rest and exercise: cardiac dysfunction vs. volume depletion J Spaak, S Montmerle, P Sundblad, D Linnarsson Journal of applied physiology 98 (2), 648-654, 2005 | 85 | 2005 |
| Risk factors and markers for acute myocardial infarction with angiographically normal coronary arteries M Daniel, C Ekenbäck, S Agewall, EB Brolin, K Caidahl, K Cederlund, ... The American journal of cardiology 116 (6), 838-844, 2015 | 76 | 2015 |
| Eligibility for renal denervation: experience at 11 European expert centers A Persu, Y Jin, M Baelen, E Vink, WL Verloop, B Schmidt, MK Blicher, ... Hypertension 63 (6), 1319-1325, 2014 | 74 | 2014 |
| Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trial K Lundwall, G Jörneskog, SH Jacobson, J Spaak American journal of nephrology 42 (4), 265-273, 2015 | 73 | 2015 |
| A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt … HJL Heerspink, D Cherney, D Postmus, BV Stefánsson, GM Chertow, ... Kidney international 101 (1), 174-184, 2022 | 68 | 2022 |
| Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction M Evans, JJ Carrero, K Szummer, A Åkerblom, R Edfors, J Spaak, ... Journal of the American College of Cardiology 67 (14), 1687-1697, 2016 | 66 | 2016 |
| Early comprehensive cardiovascular magnetic resonance imaging in patients with myocardial infarction with nonobstructive coronary arteries P Sörensson, C Ekenbäck, M Lundin, S Agewall, E Bacsovics Brolin, ... Cardiovascular Imaging 14 (9), 1774-1783, 2021 | 64 | 2021 |
| Integrating virtual patients into courses: follow‐up seminars and perceived benefit S Edelbring, O Broström, P Henriksson, D Vassiliou, J Spaak, ... Medical education 46 (4), 417-425, 2012 | 62 | 2012 |
| Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure CF Notarius, J Spaak, BL Morris, JS Floras Journal of cardiac failure 13 (6), 470-475, 2007 | 62 | 2007 |
| Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non–st-segment elevation myocardial infarction K Szummer, J Oldgren, L Lindhagen, JJ Carrero, M Evans, J Spaak, ... Jama 313 (7), 707-716, 2015 | 58 | 2015 |
| Prevalence of anxiety and depression symptoms in patients with myocardial infarction with non-obstructive coronary arteries M Daniel, S Agewall, F Berglund, K Caidahl, O Collste, C Ekenbäck, ... The American journal of medicine 131 (9), 1118-1124, 2018 | 54 | 2018 |
John S. FlorasProfessor of Medicine, University of Toronto在 utoronto.ca 的电子邮件经过验证
